Health Care/Hospital News & Press Release Distribution

Neurophet-NTU Singapore, recognized for outstanding joint research

- Neurophet accelerates global expansion for research and partnership in AI-driven brain image analysis SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, announced that Neurophet and NTU (Nanyang Technological Univers...

2024-09-09 21:00 1572

Neurophet-NTU Singapore, recognized for outstanding joint research

GenAssist Ltd Announced the First DMD Patient Dosed with its Base Editing Drug

SUZHOU, China, Sept. 9, 2024 /PRNewswire/ -- On September 06, 2024, GenAssist Ltd (GenAssist), announced the first DMD patient dosed with its base editing drug, GEN6050X injection, in an investigator-initiated trial (IIT). "This is the first-in-human trial for DMD gene editing therapy. It marks t...

2024-09-09 21:00 1220

Frost & Sullivan grants the Global Targeted Molecular Fluorescent Tracer R&D Leadership Award to Nanjing Nuoyuan Medical Devices Co., Ltd.

SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Frost & Sullivan is pleased to announce that the 18th Growth Innovation Leadership (GIL) Summit and the 3rd New Investment Event (NIE 2024), was held inShanghai from August 27 to 30, 2024, co-hosted by LeadLeo. Based on research and analysis of the global ...

2024-09-09 20:06 1347

Frost & Sullivan grants the Global Biologics CDMO Technology Leadership Award to BiBo Pharma

SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Frost & Sullivan is pleased to announce that the 18th Growth Innovation Leadership (GIL) Summit and the 3rd New Investment Event (NIE 2024), was held inShanghai from August 27 to 30, 2024, co-hosted by LeadLeo. Based on research and analysis of the global ...

2024-09-09 19:51 1528

Sirsram Medical announces NMPA approval for DAXXIFY®

Marking the introduction of the world's first and only peptide-powered botulinum toxin product to Mainland China HONG KONG, Sept. 9, 2024 /PRNewswire/ -- Sisram Medical (1696.HK), a global leading innovator and provider of holistic medical aesthetic solutions announced today that the National M...

2024-09-09 19:46 1613

Intelligent Technology Empowers the Future of Rehabilitation: Siyi Intelligence (Syrebo) Shines at WRRC 2024

i-CREATe & WRRC 2024 SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Siyi Intelligence (Syrebo) played a prominent role at the International Convention on Rehabilitation Engineering and Assistive Technology (i-CREATe 2024) & the World Rehabilitation Robot Convention 2024 (WRRC 2024), held inShanghai fro...

2024-09-09 17:41 1629

Intelligent Technology Empowers the Future of Rehabilitation: Siyi Intelligence (Syrebo) Shines at WRRC 2024

MGI Launches New Nanopore Sequencing Products with Advanced CycloneSEQ Technology

SHENZHEN, China, Sept. 9, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today announced the global rights to commercialize and distribute the new sequencing products CycloneSEQ-WT02* and CycloneS...

2024-09-09 16:24 1268

MGI Launches New Nanopore Sequencing Products with Advanced CycloneSEQ Technology

Ping An Selected for Hang Seng Corporate Sustainability Index. Series for 14th Consecutive Year

HONG KONG and SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 2318 / 82318; SSE: 601318) has been included as a constituent member in the Hang Seng Corporate Sustainability Index Series for 2024-2025...

2024-09-09 15:18 2438

A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe

Under the commercial agreement, A. Menarini Diagnostics will assume exclusive marketing of the non-invasive Bladder EpiCheck® test in Europe in the months ahead, providing patients and clinicians with a urine test to detect and monitor recurrence of bladder cancer and upper tract urothelial carci...

2024-09-09 15:00 1174

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

TAIPEI, Sept. 9, 2024 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (hereinafter referred to as "Formosa Pharma," 6838.TW) announced the successful first shipment tothe United States of its new ophthalmic drug, Clobetasol Propionate Ophthalmic Suspension, 0.05% (APP13007), manufactured by Bora P...

2024-09-09 15:00 1142

Australia Urged to Lead Global Effort Against Childhood Dementia

CANBERRA, Australia, Sept. 9 2024 /PRNewswire/ -- A groundbreaking new report, "State of Childhood Dementia inAustralia 2024," released today at Australia's Parliament House inCanberra by the Childhood Dementia Initiative, has revealed the devastating impact of childhood dementia on Australian fa...

2024-09-09 15:00 1304

Australia Urged to Lead Global Effort Against Childhood Dementia

Three Study Results Abstracts From Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) At 2024 ESMO Released Today

CHENGDU, China, Sept. 9, 2024 /PRNewswire/ -- The European Society for Medical Oncology (ESMO) Congress 2024 will be held inBarcelona, Spain from September 13 to 17, 2024. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd（"Kelun-Biotech", 6990.HK）will present the following results of its anti-TROP...

2024-09-09 14:27 1341

Three Study Results Abstracts From Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) At 2024 ESMO Released Today

EQT to acquire GeBBS Healthcare Solutions, a leading healthcare technology solutions provider

* GeBBS Healthcare Solutions ("GeBBS" or the "Company") specializes in revenue cycle management, health information management (HIM), and medical billing services * It offers a range of services designed to help US-based healthcare providers, including hospitals, health systems, and physician...

2024-09-09 14:03 1248

Antennova to Present Latest Data of ATN-037 in a Mini Oral Presentation at ESMO Congress 2024

BOSTON, Sept. 8, 2024 /PRNewswire/ -- Antennova, a clinical-stage biotech company focused on oncology today announced thatit will present the latest data of CD73 small molecule inhibitor ATN-037 in a Mini Oral presentation at the 2024 European Society of Medical Oncology Congress (ESMO Congress 2...

2024-09-09 08:30 1160

ESMO 2024 | Ascentage Pharma to Present Updated Data of Olverembatinib in Patients with SDH-Deficient GIST during a Mini Oral Presentation at the 2024 ESMO Congress

ROCKVILLE, Md. and SUZHOU, China, Sept. 9, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for malignancies, today announced that it will present the latest c...

2024-09-09 08:25 1837

Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors

New capabilities and simple, standard site experience cut trial time and expense Fixed price implementation to get up and running quickly Industry advances to connected trials as seven of the top 20 biopharmas adopt Veeva Site Connect SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Veeva System...

2024-09-09 08:00 1614

Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors

New capabilities and simple, standard site experience cut trial time and expense Fixed price implementation to get up and running quickly Industry advances to connected trials as seven of the top 20 biopharmas adopt Veeva Site Connect SYDNEY, Sept. 9, 2024 /PRNewswire/ -- Veeva Systems

2024-09-09 07:00 1499

Perioperative Ivonescimab (PD-1/VEGF) for NSCLC Demonstrated Clinically Significant Phase II Results, Presented in Oral Session at WCLC 2024

HONG KONG, Sept. 8, 2024 /PRNewswire/ -- Akeso (9926. HK) announced that its internally developed PD-1/VEGF bispecific antibody ivonescimab showed clinically significant results from a Phase II study, either as a monotherapy or in combination with chemotherapy, for the perioperative treatment of ...

2024-09-09 02:17 1487

Bc Babycare Marks a Stellar Debut at Germany's Kind+Jugend 2024

COLOGNE, Germany, Sept. 6, 2024 /PRNewswire/ -- Bc Babycare, a leader in innovative products for mothers and babies, made a remarkable debut at Kind+Jugend 2024, the premier international trade fair for baby and toddler outfitting, which opened inCologne, Germany, on September 3. The brand capti...

2024-09-06 23:22 1926

Bc Babycare Marks a Stellar Debut at Germany's Kind+Jugend 2024

Vieworks Unveils Digital Pathology Scanner LUCEON at ECP 2024

ANYANG-SI, South Korea, Sept. 6, 2024 /PRNewswire/ -- Vieworks, a leading name in bioimaging solutions, is to set a new standard in the digital pathology field with the launch of its high-speed slide scanner LUCEON 510. Vieworks will be making its debut as a digital pathology solution provider at...

2024-09-06 22:00 5487